{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T23:41:48Z","timestamp":1708213308860},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2003,8,1]],"date-time":"2003-08-01T00:00:00Z","timestamp":1059696000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neuro-Oncol"],"published-print":{"date-parts":[[2003,8]]},"DOI":"10.1007\/bf02700023","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T05:51:50Z","timestamp":1190094710000},"page":"77-87","source":"Crossref","is-referenced-by-count":2,"title":["Autologous adjuvant linked fibroblasts induce anti-glioma immunity: implications for development of a glioma vaccine"],"prefix":"10.1007","volume":"64","author":[{"given":"Andrew T.","family":"Parsa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John I.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnold E.","family":"Eggers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred T.","family":"Ogden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard C.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey N.","family":"Bruce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02700023_CR1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1053\/ctrv.2000.0191","volume":"26","author":"C Nieder","year":"2000","unstructured":"Nieder C, Grosu AL, Molls M: A comparison of treatment results for recurrent malignant gliomas. Cancer Treat Rev 26: 397\u2013409, 2000","journal-title":"Cancer Treat Rev"},{"key":"BF02700023_CR2","first-page":"3541","volume":"21","author":"N Andratschke","year":"2001","unstructured":"Andratschke N, Grosu AL, Molls M, Nieder C: Perspectives in the treatment of malignant gliomas in adults. Anticancer Res 21: 3541\u20133550, 2001","journal-title":"Anticancer Res"},{"key":"BF02700023_CR3","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1023\/A:1008267312782","volume":"9","author":"P Hosli","year":"1998","unstructured":"Hosli P, Sappino AP, de Tribolet N, Dietrich PY: Malignant glioma: should chemotherapy be overthrown by experimental treatments? Ann Oncol 9: 589\u2013600, 1998","journal-title":"Ann Oncol"},{"key":"BF02700023_CR4","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s11910-001-0024-8","volume":"1","author":"DB Paul","year":"2001","unstructured":"Paul DB, Kruse CA: Immunologic approaches to therapy for brain tumors. Curr Neurol Neurosci Rep 1: 238\u2013244, 2001","journal-title":"Curr Neurol Neurosci Rep"},{"key":"BF02700023_CR5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/pb.2000.6691","volume":"7","author":"IF Pollack","year":"2000","unstructured":"Pollack IF, Okada H, Chambers WH: Exploitation of immune mechanisms in the treatment of central nervous system cancer. Semin Pediatr Neurol 7: 131\u2013143, 2000","journal-title":"Semin Pediatr Neurol"},{"key":"BF02700023_CR6","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1073\/pnas.94.5.1914","volume":"94","author":"YT Chen","year":"1997","unstructured":"Chen YT, Scanlan MJ, Sahin U, Tureci O, Gure AO, Tsang S, Williamson B, Stockert E, Pfreundschuh M, Old LJ: A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA 94: 1914\u20131918, 1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02700023_CR7","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0301-472X(00)00550-6","volume":"28","author":"J Greiner","year":"2000","unstructured":"Greiner J, Ringhoffer M, Simikopinko O, Szmaragowska A, Huebsch S, Maurer U, Bergmann L, Schmitt M: Simultaneous expression of different immunogenic antigens in acute myeloid leukemia. Exp Hematol 28: 1413\u20131422, 2000","journal-title":"Exp Hematol"},{"key":"BF02700023_CR8","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1073\/pnas.97.8.4198","volume":"97","author":"AO Gure","year":"2000","unstructured":"Gure AO, Stockert E, Scanlan MJ, Keresztes RS, Jager D, Altorki NK, Old LJ, Chen YT: Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer. Proc Natl Acad Sci USA 97: 4198\u20134203, 2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02700023_CR9","first-page":"703","volume":"14","author":"M Itoh","year":"1999","unstructured":"Itoh M, Watanabe M, Yamada Y, Furukawa K, Taniguchi M, Hata T, Schmitt M, Ikeda H, Yamaguchi M, Ohno T, Nakashima K, Shiku H: HUB1 is an autoantigen frequently eliciting humoral immune response in patients with adult T cell leukemia. Int J Oncol 14: 703\u2013708, 1999","journal-title":"Int J Oncol"},{"key":"BF02700023_CR10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1084\/jem.187.2.265","volume":"187","author":"E Jager","year":"1998","unstructured":"Jager E, Chen YT, Drijfhout JW, Karbach J, Ringhoffer M, Jager D, Arand M, Wada H, Noguchi Y, Stockert E, Old LJ, Knuth A: Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J Exp Med 187: 265\u2013270, 1998","journal-title":"J Exp Med"},{"key":"BF02700023_CR11","first-page":"171","volume":"34","author":"H Liu","year":"2002","unstructured":"Liu H, Peng L, Ran Y, Zhang L, Zhang D, Zhu Y, Yang Z: Screening and identification of human lung cancer-related antigens. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao 34: 171\u2013175, 2002","journal-title":"Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao"},{"key":"BF02700023_CR12","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0006-291X(02)00543-0","volume":"294","author":"M Monji","year":"2002","unstructured":"Monji M, Senju S, Nakatsura T, Yamada K, Sawatsubashi M, Inokuchi A, Nishimura Y: Head and neck cancer antigens recognized by the humoral immune system. Biochem Biophys Res Commun 294: 734\u2013741, 2002","journal-title":"Biochem Biophys Res Commun"},{"key":"BF02700023_CR13","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1007\/PL00014048","volume":"46","author":"Y Obata","year":"2000","unstructured":"Obata Y, Takahashi T, Sakamoto J, Tamaki H, Tominaga S, Hamajima N, Chen YT, Old LJ: SEREX analysis of gastric cancer antigens. Cancer Chemother Pharmacol 46: S37-S42, 2000","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF02700023_CR14","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/(SICI)1097-0215(19980529)76:5<652::AID-IJC7>3.0.CO;2-P","volume":"76","author":"MJ Scanlan","year":"1998","unstructured":"Scanlan MJ, Chen YT, Williamson B, Gure AO, Stockert E, Gordan JD, Tureci O, Sahin U, Pfreundschuh M, Old LJ: Characterization of human colon cancer antigens recognized by autologous antibodies. Int J Cancer 76: 652\u2013658, 1998","journal-title":"Int J Cancer"},{"key":"BF02700023_CR15","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/(SICI)1097-0215(19991112)83:4<456::AID-IJC4>3.0.CO;2-5","volume":"83","author":"MJ Scanlan","year":"1999","unstructured":"Scanlan MJ, Gordan JD, Williamson B, Stockert E, Bander NH, Jongeneel V, Gure AO, Jager D, Jager E, Knuth A, Chen YT, Old LJ: Antigens recognized by autologous antibody in patients with renal-cell carcinoma. Int J Cancer 83: 456\u2013464, 1999","journal-title":"Int J Cancer"},{"key":"BF02700023_CR16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ijc.10170","volume":"98","author":"R Schmits","year":"2002","unstructured":"Schmits R, Cochlovius B, Treitz G, Regitz E, Ketter R, Preuss KD, Romeike BF, Pfreundschuh M: Analysis of the antibody repertoire of astrocytoma patients against antigens expressed by gliomas. Int J Cancer 98: 73\u201377, 2002","journal-title":"Int J Cancer"},{"key":"BF02700023_CR17","first-page":"285","volume":"9","author":"F Stenner-Liewen","year":"2000","unstructured":"Stenner-Liewen F, Luo G, Sahin U, Tureci O, Koslovski M, Kautz I, Liewen H, Pfreundschuh M: Definition of tumor-associated antigens in hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev 9: 285\u2013290, 2000","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BF02700023_CR18","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1038\/sj.onc.1204552","volume":"20","author":"AK Struss","year":"2001","unstructured":"Struss AK, Romeike BF, Munnia A, Nastainczyk W, Steudel WI, Konig J, Ohgaki H, Feiden W, Fischer U, Meese E: PHF3-specific antibody responses in over 60% of patients with glioblastoma multiforme. Oncogene 20: 4107\u20134114, 2001","journal-title":"Oncogene"},{"key":"BF02700023_CR19","first-page":"4766","volume":"56","author":"O Tureci","year":"1996","unstructured":"Tureci O, Sahin U, Schobert I, Koslowski M, Scmitt H, Schild HJ, Stenner F, Seitz G, Rammensee HG, Pfreundschuh M: The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40. Cancer Res 56: 4766\u20134772, 1996","journal-title":"Cancer Res"},{"key":"BF02700023_CR20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1089\/hyb.1999.18.23","volume":"18","author":"O Tureci","year":"1999","unstructured":"Tureci O, Sahin U, Zwick C, Neumann F, Pfreundschuh M: Exploitation of the antibody repertoire of cancer patients for the identification of human tumor antigens. Hybridoma 18: 23\u201328, 1999","journal-title":"Hybridoma"},{"key":"BF02700023_CR21","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1006\/bbrc.2001.6257","volume":"290","author":"Y Zhou","year":"2002","unstructured":"Zhou Y, Toth M, Hamman MS, Monahan SJ, Lodge PA, Boynton AL, Salgaller ML: Serological cloning of PARIS-1: a new TBC domain-containing, immunogenic tumor antigen from a prostate cancer cell line. Biochem Biophys Res Commun 290: 830\u2013838, 2002","journal-title":"Biochem Biophys Res Commun"},{"key":"BF02700023_CR22","first-page":"229","volume":"7","author":"AE Eggers","year":"1988","unstructured":"Eggers AE: Use of adult fibroblasts coupled to muramyl dipeptide to induce antitumor immunity. J Biol Response Mod 7: 229\u2013233, 1988","journal-title":"J Biol Response Mod"},{"key":"BF02700023_CR23","first-page":"413","volume":"3","author":"AE Eggers","year":"1984","unstructured":"Eggers AE, Tarmin L, Ginsburg S: Use of covalently bound cord factor analog to increase tumor immunogenicity. J Biol Response Mod 3: 413\u2013422, 1984","journal-title":"J Biol Response Mod"},{"key":"BF02700023_CR24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/oso\/9780199635672.003.0009","volume-title":"Cytokines: A Practical Approach","author":"J Lewis","year":"1995","unstructured":"Lewis J: Antiviral activity of cytokines. In: FR B (ed) Cytokines: A Practical Approach. Oxford University Press, Oxford, pp 129\u2013141, 1995"},{"key":"BF02700023_CR25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0167-5699(97)80008-4","volume":"18","author":"RM Zinkernagel","year":"1997","unstructured":"Zinkernagel RM, Doherty PC: The discovery of MHC restriction. Immunol Today 18: 14\u201317, 1997","journal-title":"Immunol Today"},{"key":"BF02700023_CR26","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1007\/s000180050391","volume":"55","author":"C Schindler","year":"1999","unstructured":"Schindler C, Brutsaert S: Interferons as a paradigm for cytokine signal transduction. Cell Mol Life Sci 55: 1509\u20131522, 1999","journal-title":"Cell Mol Life Sci"},{"key":"BF02700023_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/emm.1998.1","volume":"30","author":"A Raval","year":"1998","unstructured":"Raval A, Puri N, Rath PC, Saxena RK: Cytokine regulation of expression of class I MHC antigens. Exp Mol Med 30: 1\u201313, 1998","journal-title":"Exp Mol Med"},{"key":"BF02700023_CR28","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S1286-4579(99)00233-6","volume":"1","author":"JP Ting","year":"1999","unstructured":"Ting JP, Zhu XS: Class II MHC genes: a model gene regulatory system with great biologic consequences. Microbes Infect 1: 855\u2013861, 1999","journal-title":"Microbes Infect"},{"key":"BF02700023_CR29","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.4049\/jimmunol.140.10.3686","volume":"140","author":"RU Fries de","year":"1988","unstructured":"de Fries RU, Golub SH: Characteristics and mechanism of IFN-gamma-induced protection of human tumor cells from lysis by lymphokine-activated killer cells. J Immunol 140: 3686\u20133693, 1988","journal-title":"J Immunol"},{"key":"BF02700023_CR30","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1227\/00006123-199209000-00016","volume":"31","author":"S Kondo","year":"1992","unstructured":"Kondo S, Miyatake S, Kikuchi H, Oda Y, Iwasaki K, Ohyama K, Namba Y: Mechanism of interferon gamma-induced protection of human gliosarcoma cells from lymphokine-activated killer lysis: division of lymphokine-activated killer cells into natural killer- and T-like cells. Neurosurgery 31: 534\u2013540, 1992","journal-title":"Neurosurgery"},{"key":"BF02700023_CR31","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1006\/clim.2001.5152","volume":"102","author":"RC Anderson","year":"2002","unstructured":"Anderson RC, Elder JB, Brown MD, Mandigo CE, Parsa AT, Kim PD, Senatus P, Anderson DE, Bruce JN: Changes in the immunologic phenotype of human malignant glioma cells after passagingin vitro. Clin Immunol 102: 84\u201395, 2002","journal-title":"Clin Immunol"},{"key":"BF02700023_CR32","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3171\/jns.1983.59.5.0790","volume":"59","author":"K Kikuchi","year":"1983","unstructured":"Kikuchi K, Neuwelt EA: Presence of immunosuppressive factors in brain-tumor cyst fluid. J Neurosurg 59: 790\u2013799, 1983","journal-title":"J Neurosurg"},{"key":"BF02700023_CR33","first-page":"778","volume":"46","author":"IF Parney","year":"2000","unstructured":"Parney IF, Hao C, Petruk KC: Glioma immunology and immunotherapy. Neurosurgery 46: 778\u2013791; discussion 791\u2013772, 2000","journal-title":"Neurosurgery"},{"key":"BF02700023_CR34","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/00002371-200103000-00004","volume":"24","author":"Y Akasaki","year":"2001","unstructured":"Akasaki Y, Kikuchi T, Homma S, Abe T, Kofe D, Ohno T: Antitumor effect of immunizations with fusions of dendritic and glioma cells in a mouse brain tumor model. J Immunother 24: 106\u2013113, 2001","journal-title":"J Immunother"},{"key":"BF02700023_CR35","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s002620100220","volume":"50","author":"H Aoki","year":"2001","unstructured":"Aoki H, Mizuno M, Natsume A, Tsugawa T, Tsujimura K, Takahashi T, Yoshida J: Dendritic cells pulsed with tumor extract-cationic liposome complex increase the induction of cytotoxic T lymphocytes in mouse brain tumor. Cancer Immunol Immunother 50: 463\u2013468, 2001","journal-title":"Cancer Immunol Immunother"},{"key":"BF02700023_CR36","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0165-5728(99)00172-1","volume":"103","author":"AB Heimberger","year":"2000","unstructured":"Heimberger AB, Crotty LE, Archer GE, McLendon RE, Friedman A, Dranoff G, Bigner DD, Sampson JH: Bone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma. J Neuroimmunol 103: 16\u201325, 2000","journal-title":"J Neuroimmunol"},{"key":"BF02700023_CR37","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3171\/jns.1999.90.6.1115","volume":"90","author":"LM Liau","year":"1999","unstructured":"Liau LM, Black KL, Prins RM, Sykes SN, DiPatre PL, Cloughesy TF, Becker DP, Bronstein JM: Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens. J Neurosurg 90: 1115\u20131124, 1999","journal-title":"J Neurosurg"},{"key":"BF02700023_CR38","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3171\/jns.2001.94.3.0474","volume":"94","author":"R Yamanaka","year":"2001","unstructured":"Yamanaka R, Zullo SA, Tanaka R, Blaese M, Xanthopoulos KG: Enhancement of antitumor immune response in glioma models in mice by genetically modified dendritic cells pulsed with Semliki forest virus-mediated complementary DNA. J Neurosurg 94: 474\u2013481, 2001","journal-title":"J Neurosurg"},{"key":"BF02700023_CR39","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s002620100201","volume":"50","author":"S Yoshida","year":"2001","unstructured":"Yoshida S, Morii K, Watanabe M, Saito T, Yamamoto K, Tanaka R: The generation of anti-tumoral cells using dendritic cells from the peripheral blood of patients with malignant brain tumors. Cancer Immunol Immunother 50: 321\u2013327, 2001","journal-title":"Cancer Immunol Immunother"},{"key":"BF02700023_CR40","first-page":"842","volume":"61","author":"JS Yu","year":"2001","unstructured":"Yu JS, Wheeler CJ, Zeltzer PM, Ying H, Finger DN, Lee PK, Yong WH, Incardona F, Thompson RC, Riedinger MS, Zhang W, Prins RM, Black KL: Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration. Cancer Res 61: 842\u2013847, 2001","journal-title":"Cancer Res"},{"key":"BF02700023_CR41","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3171\/jns.2000.92.3.0419","volume":"92","author":"F DiMeco","year":"2000","unstructured":"DiMeco F, Rhines LD, Hanes J, Tyler BM, Brat D, Torchiana E, Guarnieri M, Colombo MP, Pardoll DM, Finocchiaro G, Brem H, Olivi A: Paracrine delivery of IL-12 against intracranial 9L gliosarcoma in rats. J Neurosurg 92: 419\u2013427, 2000","journal-title":"J Neurosurg"},{"key":"BF02700023_CR42","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3171\/jns.1994.80.3.0510","volume":"80","author":"M Mizuno","year":"1994","unstructured":"Mizuno M, Yoshida J, Takaoka T, Sugita K: Liposomal transfection of human gamma-interferon gene into human glioma cells and adoptive immunotherapy using lymphokine-activated killer cells. J Neurosurg 80: 510\u2013514, 1994","journal-title":"J Neurosurg"},{"key":"BF02700023_CR43","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/sj.gt.3300798","volume":"6","author":"H Okada","year":"1999","unstructured":"Okada H, Giezeman-Smits KM, Tahara H, Attanucci J, Fellows WK, Lotze MT, Chambers WH, Bozik ME: Effective cytokine gene therapy against an intracranial glioma using a retrovirally transduced IL-4 plus HSVtk tumor vaccine. Gene Ther 6: 219\u2013226, 1999","journal-title":"Gene Ther"},{"key":"BF02700023_CR44","doi-asserted-by":"crossref","first-page":"10399","DOI":"10.1073\/pnas.93.19.10399","volume":"93","author":"JH Sampson","year":"1996","unstructured":"Sampson JH, Archer GE, Ashley DM, Fuchs HE, Hale LP, Dranoff G, Bigner DD: Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the \u2018immunologically privileged\u2019 central nervous system. Proc Natl Acad Sci USA 93: 10399\u201310404, 1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02700023_CR45","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1349-7006.1994.tb02424.x","volume":"85","author":"T Takaoka","year":"1994","unstructured":"Takaoka T, Yoshida J, Mizuno M, Sugita K: Transfection-induced tumor necrosis factor-alpha increases the susceptibility of human glioma cells to lysis by lymphokine-activated killer cells: continuous expression of intercellular adhesion molecule-1 on the glioma cells. Jpn J Cancer Res 85: 750\u2013755, 1994","journal-title":"Jpn J Cancer Res"},{"key":"BF02700023_CR46","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1023\/A:1006289901702","volume":"43","author":"R Yamanaka","year":"1999","unstructured":"Yamanaka R, Tanaka R, Yoshida S, Saitoh T, Fujita K, Naganuma H: Suppression of TGF-\u03b21 in human gliomas by retroviral gene transfection enhances susceptibility to LAK cells. J Neuro-Oncol 43: 27\u201334, 1999","journal-title":"J Neuro-Oncol"},{"key":"BF02700023_CR47","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/00006123-199910000-00028","volume":"45","author":"RP Glick","year":"1999","unstructured":"Glick RP, Lichtor T, de Zoeten E, Deshmukh P, Cohen EP: Prolongation of survival of mice with glioma treated with semiallogeneic fibroblasts secreting interleukin-2. Neurosurgery 45: 867\u2013874, 1999","journal-title":"Neurosurgery"},{"key":"BF02700023_CR48","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1097\/00006123-199710000-00025","volume":"41","author":"RP Glick","year":"1997","unstructured":"Glick RP, Lichtor T, Mogharbel A, Taylor CA, Cohen EP: Intracerebralversus subcutaneous immunization with allogeneic fibroblasts genetically engineered to secrete interleukin-2 in the treatment of central nervous system glioma and melanoma. Neurosurgery 41: 898\u2013906; discussion 906\u2013897, 1997","journal-title":"Neurosurgery"},{"key":"BF02700023_CR49","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00002030-199509040-00018","volume":"9","author":"C Gervasoni","year":"1995","unstructured":"Gervasoni C, Ridolfo AL, Rocca A, Vago L, d\u2019Arminio Monforte A: Cerebral astrocytoma in HIV-infected patients. AIDS 9: 403\u2013404, 1995","journal-title":"AIDS"},{"key":"BF02700023_CR50","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/1097-0142(19940715)74:2<686::AID-CNCR2820740222>3.0.CO;2-K","volume":"74","author":"A Moulignier","year":"1994","unstructured":"Moulignier A, Mikol J, Pialoux G, Eliaszewicz M, Thurel C, Thiebaut JB: Cerebral glial tumors and human immunodeficiency virus-1 infection. More than a coincidental association. Cancer 74: 686\u2013692, 1994","journal-title":"Cancer"},{"key":"BF02700023_CR51","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0163-4453(96)92105-2","volume":"33","author":"JW Neal","year":"1996","unstructured":"Neal JW, Llewelyn MB, Morrison HL, Jasani B, Borysiewicz LK: A malignant astrocytoma in a patient with AIDS: a possible association between astrocytomas and HIV infection. J Infect 33: 159\u2013162, 1996","journal-title":"J Infect"},{"key":"BF02700023_CR52","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1212\/WNL.57.8.1486","volume":"57","author":"D Schiff","year":"2001","unstructured":"Schiff D, O\u2019Neill B, Wijdicks E, Antin JH, Wen PY: Gliomas arising in organ transplant recipients: an unrecognized complication of transplantation? Neurology 57: 1486\u20131488, 2001","journal-title":"Neurology"},{"key":"BF02700023_CR53","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/00006123-199903000-00110","volume":"44","author":"AP Bowles","year":"1999","unstructured":"Bowles AP Jr, Perkins E: Long-term remission of malignant brain tumors after intracranial infection: a report of four cases. Neurosurgery 44: 636\u2013642; discussion 642\u2013633, 1999","journal-title":"Neurosurgery"},{"key":"BF02700023_CR54","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.4049\/jimmunol.138.4.1297","volume":"138","author":"S Ferrini","year":"1987","unstructured":"Ferrini S, Miescher S, Zocchi MR, von Fliedner V, Moretta A: Phenotypic and functional characterization of recombinant interleukin 2 (rIL 2)-induced activated killer cells: analysis at the population and clonal levels. J Immunol 138: 1297\u20131302, 1987","journal-title":"J Immunol"},{"key":"BF02700023_CR55","first-page":"209","volume":"38","author":"EA Grimm","year":"1986","unstructured":"Grimm EA, Jacobs SK, Lanza LA, Melin G, Roth JA, Wilson DJ: Interleukin 2-activated cytotoxic lymphocytes in cancer therapy. Symp Fundam Cancer Res 38: 209\u2013219, 1986","journal-title":"Symp Fundam Cancer Res"},{"key":"BF02700023_CR56","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3171\/jns.1986.64.1.0114","volume":"64","author":"SK Jacobs","year":"1986","unstructured":"Jacobs SK, Wilson DJ, Kornblith PL, Grimm EA:In vitro killing of human glioblastoma by interleukin-2-activated autologous lymphocytes. J Neurosurg 64: 114\u2013117, 1986","journal-title":"J Neurosurg"},{"key":"BF02700023_CR57","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1749-6632.1988.tb27140.x","volume":"540","author":"J Joseph","year":"1988","unstructured":"Joseph J, D\u2019Imperio C, Knobler RL, Lublin FD: Downregulation of gamma-interferon-induced class II expression of human glioma cells by recombinant\u03b2-interferon. Ann NY Acad Sci 540: 475\u2013476, 1988","journal-title":"Ann NY Acad Sci"}],"container-title":["Journal of Neuro-oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02700023.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02700023\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02700023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T22:58:53Z","timestamp":1708210733000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02700023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8]]},"references-count":57,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2003,8]]}},"alternative-id":["BF02700023"],"URL":"https:\/\/doi.org\/10.1007\/bf02700023","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,8]]}}}